Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 2441 - 2448 of 11456 results
Climate Disclosures?!
July 14, 2021| News
Bipartisan VALID Act Re-Introduced in Congress: Is Diagnostics Reform on the Horizon?
July 13, 2021| Blog| Viewpoint
NYC Businesses: Do you have your “biometric identifier collection” notice up?
July 12, 2021| Blog| Viewpoint
Massachusetts Executive Order Permitting Massachusetts Public Companies to Hold Virtual-Only Shareholder Meetings to Expire
July 12, 2021| Advisory| Viewpoint
Busy Week for the FTC Shows Aspirations of and Limitations on Chair Khan’s Enforcement Agenda
July 9, 2021| Blog| Viewpoint
President Biden’s Competition Executive Order’s “Encouragement” to the FTC and DOJ Antitrust Division
July 9, 2021| Alert| Viewpoint
Apple Trial Spotlights U.K. Ban Potential in Global Patent Fights
July 8, 2021| News
NY HERO Act Standards & Template Policies Released – Employer Action Required
July 8, 2021| Blog| Viewpoint
News & Press Releases
Mintz is pleased to announce that 31 attorneys have been named Massachusetts Super Lawyers and 35 attorneys have been named Massachusetts Rising Stars for 2024.
Mintz IP Group Named “Litigation Department of the Year” in 2024 New England Legal Awards
October 02, 2024
Mintz’s intellectual property litigation group was named “Litigation Department of the Year” for the IP specialty category in the 2024 New England Legal Awards. The awards recognize attorneys and firms in Connecticut, Maine, Vermont, New Hampshire, Massachusetts, and Rhode Island.
Defending AI, Machine Learning Patents In Life Sciences
October 1, 2024
Intellectual Property Chair Michael Renaud and Associates Meena Seralathan, Simone Yhap, and Williams Dixon recently wrote an article for Law360 focused on protecting artificial intelligence and machine learning patents in the life sciences industry following the US Supreme Court’s 2014 decision in Alice v. CLS Bank.